Home - Products - Microbiology/Virology - Antibiotic - REV 5901A

REV 5901A

CAS No. 92532-23-5

REV 5901A( —— )

Catalog No. M33762 CAS No. 92532-23-5

REV 5901A (REV 5901 HCl) is an orally active leukotriene receptor antagonist and 5-lipoxygenase inhibitor with antimicrobial activity that attenuates colon cancer growth in mice.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
2MG	163	In Stock
5MG	276	In Stock
10MG	394	In Stock
25MG	616	In Stock
100MG	Get Quote	In Stock
200MG	Get Quote	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

REV 5901A
Note

Research use only, not for human use.
Brief Description

REV 5901A (REV 5901 HCl) is an orally active leukotriene receptor antagonist and 5-lipoxygenase inhibitor with antimicrobial activity that attenuates colon cancer growth in mice.
Description

REV 5901A (REV 5901 HCl) is an orally active leukotriene receptor antagonist and 5-lipoxygenase inhibitor with antimicrobial activity that attenuates colon cancer growth in mice.REV 5901A has been used in studies of asthma and myocardial infarction. REV 5901A is used to study asthma and myocardial infarction.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Microbiology/Virology
Target

Antibiotic
Recptor

Antibiotic | Lipoxygenase | Leukotriene Receptor
Research Area

——
Indication

——

Chemical Information

CAS Number

92532-23-5
Formula Weight

371.9
Molecular Formula

C22H26ClNO2
Purity

>98% (HPLC)
Solubility

——
SMILES

Cl.OC(C=1C=CC=C(OCC2=NC=3C=CC=CC3C=C2)C1)CCCCC
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Phleomycin

Phleomycin is one of the anticancer glycopeptide antibiotics which cause DNA cleavage.
Cefuzonam

Cefuzonam is a novel cephalosporin with anti-inflammatory and antibacterial activity that can be used in studies of respiratory tract infections, tonsillitis, and hepatobiliary infections.
BMS626529

BMS-626529 is a novel attachment inhibitor that targets HIV-1 gp120 and prevents its binding to CD4+ T cells.

Sign In Join Free